Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells

Molecular Cancer Therapeutics
Maria SerovaEric Raymond

Abstract

PEP005 (ingenol-3-angelate) is a novel anticancer agent extracted from Euphorbia peplus that was previously shown to modulate protein kinase C (PKC), resulting in antiproliferative and proapoptotic effects in several human cancer cell lines. In Colo205 colon cancer cells, exposure to PEP005 induced a time- and concentration-dependent decrease of cells in S phase of cell cycle and apoptosis. In Colo205 cells exposed to PEP005, a variety of signaling pathways were activated as shown by increased phosphorylation of PKCdelta, Raf1, extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase (MAPK), c-Jun NH(2)-terminal kinase, p38 MAPK, and PTEN. PEP005-induced activation of PKCdelta was associated with its translocation from the cytosol to the nucleus and other cellular membranes. Interestingly, PEP005 treatment also resulted in reduced expression of PKCalpha and reduced levels of phosphorylated active form of AKT/protein kinase B. These data suggest that PEP005-induced activation of PKCdelta and reduced expression of PKCalpha resulted in apoptosis by mechanisms mediated by activation of Ras/Raf/MAPK and inhibition of the phosphatidylinositol 3-kinase/AKT signaling pathways. This study supports ongoing efforts targe...Continue Reading

References

Jan 1, 1988·The Australasian Journal of Dermatology·A C Green, G L Beardmore
Dec 1, 1995·The Journal of Biological Chemistry·A C Newton
May 31, 1996·The Journal of Biological Chemistry·J Y LeeL M Obeid
Jan 31, 1998·The Journal of Biological Chemistry·P S LorenzoP M Blumberg
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Mar 17, 1999·Biochimica Et Biophysica Acta·P W Schenk, B E Snaar-Jagalska
Apr 29, 2000·Trends in Pharmacological Sciences·K J WayG L King
May 24, 2000·Oncogene·T CrossJ M Lord
Jun 10, 2000·Molecular and Cellular Biology·A Besson, V W Yong
Feb 15, 2001·Cell Death and Differentiation·M E ReylandA A Matassa
Jan 5, 2002·Expert Opinion on Investigational Drugs·P G Goekjian, M R Jirousek
Jan 10, 2002·The EMBO Journal·Amardeep S DhillonWalter Kolch
Dec 31, 2003·The Journal of Biological Chemistry·Tarek AbbasJill Bargonetti
Mar 23, 2004·Current Cancer Drug Targets·Johann Hofmann
May 6, 2004·Cancer Research·Noemi KedeiPeter M Blumberg
Dec 25, 2004·Cell Death and Differentiation·A M D'Costa, M F Denning
Feb 1, 2007·Anti-cancer Drugs·Steven M OgbourneAndreas Suhrbier
May 15, 2007·Oncogene·A S DhillonW Kolch

❮ Previous
Next ❯

Citations

Sep 8, 2012·Clinical, Cosmetic and Investigational Dermatology·Brian Berman
Jan 1, 2009·Cancer Management and Research·Gunter SchuchCarsten Bokemeyer
May 17, 2011·Investigational New Drugs·Sylvie Négrier, Eric Raymond
Apr 2, 2009·Current Oncology Reports·Kevin D Courtney, Toni K Choueiri
Oct 19, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jian-Ye ZhangHu-Biao Chen
Dec 19, 2012·Journal of the American Academy of Dermatology·George Martin, Neil Swanson
Mar 3, 2010·Progress in Lipid Research·Patricia GangoitiAntonio Gómez-Muñoz
Nov 30, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ming LiuJing Li
Mar 11, 2015·Journal of Cellular and Molecular Medicine·Zhenming JiangXi Chen
Mar 18, 2009·Biochemical and Biophysical Research Communications·Ya Chun WuChi Hin Cho
May 14, 2014·Frontiers in Chemistry·Christine BasmadjianLaurent G Désaubry
Aug 28, 2016·Journal of Photochemistry and Photobiology. B, Biology·Andrés M ErlendssonMerete Hædersdal
Aug 23, 2016·International Journal of Molecular Sciences·Ming LiuJinlai Miao
Apr 10, 2014·Journal of the American Chemical Society·Steven J McKerrallPhil S Baran
Feb 7, 2014·Journal of Natural Products·Gordon M CraggDavid J Newman
Jan 1, 2011·Cancers·Barbara MarengoCinzia Domenicotti
Jan 18, 2018·International Journal of Molecular Sciences·Ana M L Seca, Diana C G A Pinto
Jul 15, 2015·Chemical Society Reviews·Tegan P Stockdale, Craig M Williams
May 16, 2013·Journal of Cutaneous Medicine and Surgery·Aditya K Gupta, Maryse Paquet
Nov 7, 2018·Journal of Receptor and Signal Transduction Research·Kranthi Kumar KonidalaNeeraja Pabbaraju
Nov 28, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Viviane Aline Oliveira SilvaRui Manuel Reis
May 22, 2019·Cancers·Sébastien DupasquierCorinne Prévostel
Jun 28, 2015·Molecular Cancer Therapeutics·Sandra N FreibergerGünther F L Hofbauer
May 7, 2021·Molecular Oncology·Matheus Henrique Dias, René Bernards
Jun 17, 2021·Journal of Agricultural and Food Chemistry·Asifa KhanMohammad Askandar Iqbal
Jul 4, 2021·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Rishi Kant SinghArbind Acharya

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis